Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans

C. N. Andrews, A. E. Bharucha, M. Camilleri, P. A. Low, B. M. Seide, D. D. Burton, K. K. Nickander, K. L. Baxter, A. R. Zinsmeister

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


In humans, glucagon-like peptide-1 (GLP-1) delays gastric emptying by inhibiting vagal activity and also increases gastric volumes, by unclear mechanisms. Because GLP-1 inhibits intestinal motility by stimulating the sympathetic nervous system in rats, we assessed the effects of a GLP-1 agonist and yohimbine, an α2-adrenergic antagonist, on gastric volumes in humans. In this double-blind study, 32 healthy volunteers were randomized to placebo, a GLP-1 agonist, yohimbine or GLP-1 and yohimbine. Gastric volumes (fasting predrug and postdrug, and postprandial postdrug) were measured by 99mTc single photon emission computed tomography imaging. Plasma catecholamines and haemodynamic parameters were assessed. Compared with placebo, GLP-1 increased (P = 0.03) but yohimbine did not affect fasting gastric volume. However, GLP-1 plus yohimbine increased (P < 0.001) postprandial gastric accommodation vs placebo and vs GLP-1 alone [postprandial volume change = 542 ± 29 mL (mean ± SEM, placebo), 605 ± 31 mL (GLP-1), 652 ± 54 mL (yohimbine) and 810 ± 37 mL (GLP-1 and yohimbine)]. Plasma noradrenaline and dihydroxyphenylglycol concentrations were higher for yohimbine vs placebo and for GLP-1 and yohimbine vs GLP-1. Yohimbine stimulates central sympathetic activity and in combination with GLP-1, augments postprandial accommodation in humans.

Original languageEnglish (US)
Pages (from-to)716-723
Number of pages8
JournalNeurogastroenterology and Motility
Issue number9
StatePublished - Sep 2007


  • Accommodation
  • GLP-1
  • Stomach
  • Stress
  • Sympathetic
  • Yohimbine

ASJC Scopus subject areas

  • Physiology
  • Endocrine and Autonomic Systems
  • Gastroenterology


Dive into the research topics of 'Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans'. Together they form a unique fingerprint.

Cite this